Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
Extracellular vesicles are released from cells and permit communication between different cell types. Here, the authors identify that the FDA approved antibiotic sulfisoxazole, can block the release of these vesicles in breast cancer cells resulting in reduced cell growth in vitro and in vivo.
Guardado en:
Autores principales: | Eun-Ju Im, Chan-Hyeong Lee, Pyong-Gon Moon, Gunassekaran Gowri Rangaswamy, Byungheon Lee, Jae Man Lee, Jae-Chul Lee, Jun-Goo Jee, Jong-Sup Bae, Taeg-Kyu Kwon, Keon-Wook Kang, Myeong-Seon Jeong, Joo-Eun Lee, Hyun-Suk Jung, Hyun-Joo Ro, Sangmi Jun, Wonku Kang, Seung-Yong Seo, Young-Eun Cho, Byoung-Joon Song, Moon-Chang Baek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/564a9fb0ea3542299cb37cacb0869df3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to ‘Sulfisoxazole does not inhibit the secretion of small extracellular vesicles’
por: Chan-Hyeong Lee, et al.
Publicado: (2021) -
Effects of a BMI1008 mixture on postoperative pain in a rat model of incisional pain.
por: Geun Joo Choi, et al.
Publicado: (2021) -
Significant elevation of aqueous endothelin-1 in central retinal vein occlusion.
por: Hae Min Kang, et al.
Publicado: (2021) -
Impact of process-dependent SiNx passivation on proton-induced degradation in GaN MIS-HEMTs
por: Young Jun Yoon, et al.
Publicado: (2021) -
Low-profile high efficiency transmitarray antenna using optimized phase compensation surface (PCS) and PEC sidewalls
por: Jeong-Hyun Park, et al.
Publicado: (2021)